Second conslusions of annual cluster meeting and policy brief
(odnośnik otworzy się w nowym oknie)
Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster including policy brief formulating recommendations based on the research and innovation strand of the ‘Diagnosis and treatment’ annual cluster meeting
Decision making model, measures and study protocol
(odnośnik otworzy się w nowym oknie)
Overview of the model describing the process of decision-making in situations of therapeutic uncertainty (with supporting literature and development process) and protocol of the mixed-methods study to investigate it
Report of the BRCA mutation and homologous recombination status used in real-life setting
(odnośnik otworzy się w nowym oknie)
Inventory of the assays used in the different centers for assessing the HRD status (BRCA mutation, genomic instability, other), and description of level of evidence for each assay
Submission package including clinical trial documents
(odnośnik otworzy się w nowym oknie)
Study initiation package (before enrolment of the first study participant) including: •Registration number of the clinical study in a registry meeting WHO Registry criteria (see also references given in subheading 1.1 of this template)•Final version of study protocol as approved by the regulator(s) / ethics committee(s)•Regulatory and ethics (if applicable, institutional) approvals required for the enrolment of the first study participant (In case of multicentre clinical studies, submission of approvals for the first clinical site is sufficient.)
Statistical analysis plan
(odnośnik otworzy się w nowym oknie)
Document describing how the data will be analysed with regard to the objectives of the study
Dissemination and communication activities from M1 to M36
(odnośnik otworzy się w nowym oknie)
Consortium workshops, Conference workshops, Abstracts, Publications in peer-reviewed journals, Flyers, Newsletters, and presentations realized from M1 to M 36
Statistical analysis plan of HR-QoL data
(odnośnik otworzy się w nowym oknie)
Report of the statistical analysis plan of quality of life data, with respect to the objectives of the clinical trial concerning Quality of Life issues
Projet logo, presentations template, press releases
(odnośnik otworzy się w nowym oknie)
Logo of the SALVOVAR project. Template to be applied for all the presentations concerning SALVOVAR project, Press releases to announce SALVOVAR project
First conclusions of annual cluster meeting and policy brief
(odnośnik otworzy się w nowym oknie)
Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster and policy brief formulating recommendations based on the research and innovation strand of the ‘Diagnosis and treatment’ annual cluster meeting
Work plan for cluster activities
(odnośnik otworzy się w nowym oknie)
Initial common work plan for scientific collaboration under the ‘Diagnosis and treatment’ cluster
Translated Questionnaires of Quality of Life
(odnośnik otworzy się w nowym oknie)
Questionnaires of quality of Life translated in local languages of all participating centres
Intermediate trial conduction and safety report
(odnośnik otworzy się w nowym oknie)
Trial conduction and safety report at the end of the inclusions
Centralized reviewing of eligibility criteria based on surgery outcome
(odnośnik otworzy się w nowym oknie)
Operative ESGO report and mandatory field for inclusion edited
Dissemination and communication plan V1
(odnośnik otworzy się w nowym oknie)
Release of the first dissemination and communication plan of SALVOVAR project
Mid-term Recruitment report
(odnośnik otworzy się w nowym oknie)
This report is due when 50% of the study population is recruited. The report shall include an overview of the number of recruited participants by clinical sites, any problems in recruitment and, if applicable, a detailed description of implemented and planned measures to compensate for any incurred delays.
Harmonized stratification criteria
(odnośnik otworzy się w nowym oknie)
List of non-resectability criteria edited
